European Society of Contraception Statement on Contraception in Obese Women

Gabriele S Merki-Feld; Sven Skouby; David Serfaty; Medard Lech; Johannes Bitzer; Pier Giorgio Crosignani; Angelo Cagnacci; Regine Sitruk-Ware

doi:10.3109/13625187.2014.960561

European Society of Contraception Statement on Contraception in Obese Women

Gabriele S Merki-Feld, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci, Regine Sitruk-Ware

Department of Clinical Medicine

24 Citations (Scopus)

Abstract

The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

Original language	English
Journal	European Journal of Contraception and Reproductive Health Care
Volume	20
Issue number	1
Pages (from-to)	19-28
Number of pages	10
ISSN	1362-5187
DOIs	https://doi.org/10.3109/13625187.2014.960561
Publication status	Published - 1 Feb 2015

Keywords

Contraception
Contraception, Postcoital
Contraceptive Agents, Female
Developed Countries
Europe
Female
Humans
Intrauterine Devices, Medicated
Obesity
Overweight
Pregnancy
Societies, Medical
Venous Thromboembolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/13625187.2014.960561

Cite this

@article{280983c4fd8441a0a07be66c27502d4a,

title = "European Society of Contraception Statement on Contraception in Obese Women",

abstract = "The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.",

keywords = "Contraception, Contraception, Postcoital, Contraceptive Agents, Female, Developed Countries, Europe, Female, Humans, Intrauterine Devices, Medicated, Obesity, Overweight, Pregnancy, Societies, Medical, Venous Thromboembolism",

author = "Merki-Feld, {Gabriele S} and Sven Skouby and David Serfaty and Medard Lech and Johannes Bitzer and Crosignani, {Pier Giorgio} and Angelo Cagnacci and Regine Sitruk-Ware",

year = "2015",

month = feb,

day = "1",

doi = "10.3109/13625187.2014.960561",

language = "English",

volume = "20",

pages = "19--28",

journal = "The European Journal of Contraception and Reproductive Health Care",

issn = "1362-5187",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - European Society of Contraception Statement on Contraception in Obese Women

AU - Merki-Feld, Gabriele S

AU - Skouby, Sven

AU - Serfaty, David

AU - Lech, Medard

AU - Bitzer, Johannes

AU - Crosignani, Pier Giorgio

AU - Cagnacci, Angelo

AU - Sitruk-Ware, Regine

PY - 2015/2/1

Y1 - 2015/2/1

N2 - The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

AB - The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

KW - Contraception

KW - Contraception, Postcoital

KW - Contraceptive Agents, Female

KW - Developed Countries

KW - Europe

KW - Female

KW - Humans

KW - Intrauterine Devices, Medicated

KW - Obesity

KW - Overweight

KW - Pregnancy

KW - Societies, Medical

KW - Venous Thromboembolism

U2 - 10.3109/13625187.2014.960561

DO - 10.3109/13625187.2014.960561

M3 - Journal article

C2 - 25380138

SN - 1362-5187

VL - 20

SP - 19

EP - 28

JO - The European Journal of Contraception and Reproductive Health Care

JF - The European Journal of Contraception and Reproductive Health Care

IS - 1

ER -

European Society of Contraception Statement on Contraception in Obese Women

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this